Announcements Trials

Browse Landscape

Phase

Phase NA 4 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2 Sleep Wake Disorders 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Overweight 1 Obesity 1 Motor Activity 1 Hematologic Neoplasms 1 Head and Neck Carcinoma 1 Fatigue 1 Endometrial Neoplasms 1 Disease 1 Depressive Disorder 1 Depression 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Psilocybin 6 Therapeutics 2 Ketamine 2 Exercise 2 Venlafaxine Hydrochloride 1 Vegetables 1 Terminal Care 1 Self-Management 1 SLI381 1 Psychotherapy 1 Psychosocial Intervention 1 Psychiatric Rehabilitation 1 Professional Autonomy 1 Niacin 1 Mirtazapine 1 Minocycline 1 Methylphenidate 1 Mental Status and Dementia Tests 1 Melatonin 1 Medical Marijuana 1 Interpersonal Psychotherapy 1 Injections 1 Infliximab 1 Gemcitabine 1 Fruit 1 Fluoxetine 1 Ethanol 1 Doxorubicin 1 Donepezil 1 Dignity Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Depression × Counseling × Clear all

NCT01748734 2015-06-04

Cognitive Therapy in Reducing Depression in Patients With Cancer

Ohio State University Comprehensive Cancer Center

Phase 2 Completed

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡